Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.03
0.0000
Volume:- -
Turnover:- -
Market Cap:882.64M
PE:16.30
High:17.03
Open:17.03
Low:17.03
Close:17.03
52wk High:21.03
52wk Low:13.08
Shares:51.83M
Float Shares:25.86M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.05
EPS(LYR):2.06
ROE:20.91%
ROA:1.33%
PB:3.05
PE(LYR):8.27

Loading ...

Theravance Biopharma downgraded to Neutral from Buy at BTIG

TIPRANKS
·
Jun 29

Theravance Biopharma Inc : Btig Cuts to Neutral from Buy

THOMSON REUTERS
·
Jun 29

Zymeworks Down 6.1%

THOMSON REUTERS
·
Jun 29

Theravance Biopharma Inc : Jonestrading Cuts to Hold Rating

THOMSON REUTERS
·
Jun 29

Zymeworks Posts Investor Presentation on Planned Theravance Biopharma Acquisition for Yupelri Cash Flows

Reuters
·
Jun 29

Deals of the Day-mergers and Acquisitions

Reuters
·
Jun 29

Why This Biotech Stock is Falling After a $929 Million Buyout Lifeline

Dow Jones
·
Jun 29

Theravance Biopharma: Co to Pay $32.5 Mln Termination Fee to Zymeworks, if Deal Terminated Under Certain Circumstances

THOMSON REUTERS
·
Jun 29

Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash

TIPRANKS
·
Jun 29

Theravance Biopharma Shares Fall 3.3% Premarket; Co to be Acquired by Zymeworks for $17 Per Share in Cash Plus a Contingent Value Right

THOMSON REUTERS
·
Jun 29

Zymeworks to Acquire Theravance Biopharma for USD 17 Per Share in USD 929 Million Deal

Reuters
·
Jun 29

Theravance Biopharma - Strategic Review Committee and Board Unanimously Approve and Recommend Deal

THOMSON REUTERS
·
Jun 29

Theravance Biopharma - Deal Represents Equity Value of About $929 Mln

THOMSON REUTERS
·
Jun 29

Theravance Biopharma - to be Bought by Zymeworks for $17 Per Share in Cash Plus CVR

THOMSON REUTERS
·
Jun 29

Theravance Biopharma - Shareholders to Receive CVR for 80% of Net Proceeds from Ampreloxetine Monetization

THOMSON REUTERS
·
Jun 29

Zymeworks - Deal Financed by $350 Mln Non-recourse Note, $360 Mln Net Cash, $219 Mln Zymeworks Cash

THOMSON REUTERS
·
Jun 29

Zymeworks - Deal Expected to be Accretive to Earnings and Cash Flow

THOMSON REUTERS
·
Jun 29

Zymeworks - to Retain $2.5 Bln Irish Tax Attributes from Theravance Biopharma

THOMSON REUTERS
·
Jun 29

Zymeworks - Theravance Biopharma Expected to Receive $100 Mln Trelegy Ellipta Milestone in Q1 2027

THOMSON REUTERS
·
Jun 29

Zymeworks Said to Near $929 Million Deal for Theravance - Bloomberg News

Reuters
·
Jun 29